Trial

A Phase IIa, Open Label Study to Determine the EBA, Extended EBA and Pharmacokinetic Study of LL3858 for the Treatment of Newly Diagnosed Sputum Smear-Positive Pulmonary TB

Study Director
Start Date
0 / 0
Trial Phase
Trial Status
study in development
Current Enrollment
Target Enrollment
Overview
Compound Associations
LL 3858